192
Participants
Start Date
June 13, 2023
Primary Completion Date
July 4, 2024
Study Completion Date
January 23, 2025
vobramitamab duocarmazine 2.0 mg (Arm A)
2.0 mg/kg intravenous (IV) every 4 weeks
vobramitamab duocarmazine 2.7 mg (Arm B)
2.7 mg.kg IV every 4 weeks
vobramitamab duocarmazine
2.7 mg.kg IV every 4 weeks
Abiraterone
1000 mg once daily
Enzalutamide
160 mg daily
Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert
Ramsay Health Care - Westmead Private Hospital, Westmead
Peter MacCallum Cancer Centre, Melbourne
Cabrini Health- Malvern, Malvern
The University of Queensland (UQ) - Princess Alexandra Hospital (PAH), Woolloongabba
Centre Hospitalier Universitaire (CHU) - Universite Catholique de Louvain (UCL) - Namur - Site Godinne (Cliniques Universitaires UCL de Mont-Godinne), Godinne
Asan Medical Center, Seoul
(Grand Hopital de Charleroi) GHDC, Charleroi
Centre Hospitalier de Ardenne - Libramont - Clinique du Sein, Libramont
Algemeen Ziekenhuis Maria Middelares, Ghent
AOU San Luigi Gonzaga Oncology Department, Orbassano
National Cancer Center, Goyang-si
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Virginia Cancer Specalists, Fairfax
University of Virginia Comprehensive Cancer Center, Charlottesville
Hospital Universitario Lucus Augusti, Lugo
Hospital Universitario 12 de Octubre, Madrid
CHRU Brest, Brest
Carolina Urologic Research Center, Myrtle Beach
Ospedale dell'Angelo, Mestre
The University of Florida Health System - UF Health Urology - Jacksonville, Jacksonville
Mid Florida Hematology and Oncology Center, Orange City
Institut Bergonié, Bordeaux
Institut régional du Cancer de Montpellier - ICM Val d'Aurelle, Montpellier
Istituto Oncologico Veneto, Padua
Centre Hospitalier Privé Saint-Grégoire, Saint-Grégoire
Azienda Provinciale per i Servizi Sanitari - Presidio Ospedaliero S. Chiara, Trento
Hospital Universitario Virgen del Rocio, Seville
Kyungpook National University Chilgok Hospital, Bugok
Gabrail Cancer Center, Canton
Barbara Ann Karmanos Cancer Institute - Hudson-Webber Cancer Research Center, Detroit
Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence
Masonic Cancer Center, University of Minnesota, Minneapolis
Chonnam National University Hospital, Gwangju
Institut de Cancerologie Strasbourg Europe (ICANS), Strasbourg
Pontchartrain Cancer Center, Covington
Clinique Victor Hugo, Le Mans
Institut Mutualiste Montsouris, Paris
University of California Los Angeles (UCLA) Community Cancer Care, Los Angeles
Hopital Foch, Suresnes
Compassionate Cancer Care Medical Group, Fountain Valley
Hôpital d'Instruction des Armées Bégin, Saint-Mandé
Gustave Roussy, Villejuif
VA Portland Health Care Services, Portland
Fred Hutchinson Cancer Center, Seattle
Centre Antoine-Lacassagne, Nice
Szpital im. Fryderyka Chopina, Otwock
Magodent Szpital Elblaska, Warsaw
Medical Concierge Centrum Medyczne, Warsaw
Grochowski Hospital, Warsaw
Szpital Wojewodzki im. Mikolaja Kopernika, Koszalin
"Przychodnia Lekarska KOMED", Konin
Seoul National University Hopital, Seoul
Yonsei University Health System, Severance Hospital, Seoul
Samsung Meical Cemter, Seoul
Ewha Womans University Mokdong Hospital, Seoul
Hospital Universitari Parc Taulí, Sabadell
Hospital Del Mar, Barcelona
Hospital Clinic de Barcelona, Barcelona
Hospital de la Santa Creu I Sant Pau, Barcelona
Institut Catala d'Oncologia Hospitalet, Barcelona
The Royal Marsden NHS Trust, Sutton
Oxford University Hospitals NHS- Churchill Hospital, Oxford
Lead Sponsor
MacroGenics
INDUSTRY